Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2026-01-17 @ 10:15 AM
Study NCT ID:
NCT06305702
Status:
COMPLETED
Last Update Posted:
2024-03-12
First Post:
2024-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer
Sponsor:
Liaoning Cancer Hospital & Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2024-03-05
First Submit QC Date:
None
Study First Post Date:
2024-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-05
Last Update Post Date:
2024-03-12
Last Update Post Date Type:
ACTUAL